The clinical curative effect and safety of Shenqifuzheng injection in the treatment of elderly patients with chronic heart failure
10.3969/j.issn.1005-1678.2017.04.044
- VernacularTitle:参芪扶正注射液治疗老年慢性心力衰竭的临床疗效及安全性
- Author:
Fujun CHEN
;
Lichao CHEN
- Keywords:
Shenqifuzheng injection;
gerontism;
chronic heart failure;
clinical efficacy;
safety
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(4):137-139
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical curative effect and safety of Shenqifuzheng injection in the treatment of elderly patients with chronic heart failure.Methods 58 cases of elderly patients with chronic heart failure were selected from September 2014 to September 2015 in our hospital and randomly divided into the control group and treatment group,29 cases in each group.The control group was given conventional therapy,on the basis of the control group,the experimental group was treated with Shenqifuzheng injection,250mL,one time a day,intravenous drip;Before and after treatment,compared between the two groups of patients with serum tumor necrosis factorα(TNF-α),interleukin 1β levels,efficiency of treatment and safety.Results After treatment,compared with the control group,the serum levels of TNF-α and IL-1β were lower in the experimental group(P<0.05); the treatment efficiency of the experimental group(93.11％)was significantly higher than that of the control group(65.52％,P<0.05).Conclusion The Shenqifuzheng injection can significantly reduce the serum levels of TNF-α and IL-1βin elderly patients with chronic heart failure,reduce inflammatory reaction,improve clinical efficacy,and safety was high.
